These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

715 related items for PubMed ID: 28593615

  • 1. A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.
    Hohendorff J, Szopa M, Skupien J, Kapusta M, Zapala B, Platek T, Mrozinska S, Parpan T, Glodzik W, Ludwig-Galezowska A, Kiec-Wilk B, Klupa T, Malecki MT.
    Endocrine; 2017 Aug; 57(2):272-279. PubMed ID: 28593615
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers.
    Gloyn AL, Faber JH, Malmodin D, Thanabalasingham G, Lam F, Ueland PM, McCarthy MI, Owen KR, Baunsgaard D.
    PLoS One; 2012 Aug; 7(7):e40962. PubMed ID: 22859960
    [Abstract] [Full Text] [Related]

  • 6. Insights from basic adjunctive examinations of GCK-MODY, HNF1A-MODY, and type 2 diabetes: A systemic review and meta-analysis.
    Liu J, Xiao X, Zhang Q, Yu M.
    J Diabetes; 2023 Jun; 15(6):519-531. PubMed ID: 37226652
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations.
    Ben Khelifa S, Martinez R, Dandana A, Khochtali I, Ferchichi S, Castaño L.
    Gene; 2018 Apr 20; 651():44-48. PubMed ID: 29408271
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
    Østoft SH.
    Dan Med J; 2015 Sep 20; 62(9):. PubMed ID: 26324089
    [Abstract] [Full Text] [Related]

  • 13. Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing.
    López-Garrido MP, Herranz-Antolín S, Alija-Merillas MJ, Giralt P, Escribano J.
    Clin Endocrinol (Oxf); 2013 Sep 20; 79(3):342-7. PubMed ID: 23009393
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
    Besser RE, Shepherd MH, McDonald TJ, Shields BM, Knight BA, Ellard S, Hattersley AT.
    Diabetes Care; 2011 Feb 20; 34(2):286-91. PubMed ID: 21270186
    [Abstract] [Full Text] [Related]

  • 19. An Italian MODY family with proband and son carrying variants in GCK and HFN1A: is it a true case of digenic MODY?
    Lucchesi D, Randazzo E, Del Prato S, Bianchi C.
    Acta Diabetol; 2024 Jan 20; 61(1):131-134. PubMed ID: 37730861
    [Abstract] [Full Text] [Related]

  • 20. Coinheritance of HNF1A and glucokinase variants in maturity-onset diabetes of the young.
    Watanabe D, Yagasaki H, Narusawa H, Inukai T.
    Endocrinol Diabetes Metab Case Rep; 2024 Jul 01; 2024(3):. PubMed ID: 39089324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.